Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.080
-0.030 (-1.42%)
Aug 4, 2026, 2:52 PM EDT - Market open

Lipocine Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4.985.216.214.773.152.95
Short-Term Investments
18.299.7215.4317.2629.3841.67
Cash & Short-Term Investments
23.2714.9321.6322.0432.5344.62
Cash Growth
29.72%-30.98%-1.82%-32.26%-27.09%126.86%
Other Receivables
0.291.160.210.050.080.25
Total Trade Receivables
0.291.160.210.050.080.25
Other Current Assets
0.180.790.480.771.521.51
Total Current Assets
23.7416.8822.3222.8634.1446.38
Net Property, Plant & Equipment
0.070.10.170.120.130.01
Long-Term Investments
-----2.02
Other Long-Term Assets
0.020.020.020.023.284.07
Total Assets
23.8417.0122.512337.5452.48

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.680.970.271.40.61.29
Accrued Expenses
1.071.240.921.221.081.02
Current Portion of Long-Term Debt
-----2.31
Unearned Revenue
0.320.320.32---
Other Current Liabilities
---0.02-1
Total Current Liabilities
2.072.531.512.631.685.62
Other Long-Term Liabilities
----0.231.3
Total Long-Term Liabilities
----0.231.3
Total Liabilities
2.072.531.512.631.916.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Treasury Stock
-0.04-0.04-0.04-0.04-0.04-0.04
Additional Paid-in Capital
237.5223.9220.79220.17219.11218.29
Accumulated Other Comprehensive Income
-0.0100.010.01-0.02-0.02
Retained Earnings
-215.69-209.4-199.77-199.78-183.43-172.67
Shareholders' Equity
21.7714.482120.3735.6345.57
Total Liabilities & Equity
23.8417.0122.512337.5452.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-00002.31
Net Cash (Debt)
23.2714.9321.6322.0432.5342.31
Net Cash Growth
29.72%-30.98%-1.82%-32.26%-23.11%200.54%
Net Cash Per Share
3.432.623.994.186.198.21
Book Value
21.7714.482120.3735.6345.57
Book Value Per Share
3.212.543.873.876.788.84
Tangible Book Value
21.7714.482120.3735.6345.57
Tangible Book Value Per Share
3.212.543.873.876.788.84
SEC Filings: 10-K · 10-Q